We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Protalix Holds Pre-NDA Meeting with FDA for prGCD

News   Jul 15, 2009

 
Protalix Holds Pre-NDA Meeting with FDA for prGCD
 
 
 

RELATED ARTICLES

Drug Seeks Out Receptors in Sarcoma Cells, Shrinks Tumors

News

A new compound that targets a receptor within sarcoma cancer cells shrank tumors and hampered their ability to spread in mice and pigs, a study from researchers at the University of Illinois reports.

READ MORE

The Source of Stem Cells Points to Two Proteins

News

Negative feedback between HIPPO and Par complex components ensure robust lineage segregation in mice.

READ MORE

Statins Have Low Risk of Side Effects

News

The cholesterol-lowering drugs called statins have demonstrated substantial benefits in reducing the risk of heart attacks and strokes caused by blood clots (ischemic strokes) in at-risk patients. Since statins are associated with a low risk of side effects, the benefits of taking them outweigh the risks, according to a scientific statement from the American Heart Association that reviewed multiple studies evaluating the safety and potential side effects of these drugs.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE